Zurich Cantonal Bank’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.08M | Buy |
47,853
+2,280
| +5% | +$164K | 0.01% | 777 |
|
|
2026
Q1 | $3M | Buy |
45,573
+9,159
| +25% | +$582K | 0.01% | 833 |
|
|
2025
Q4 | $2.31M | Buy |
36,414
+4,159
| +13% | +$259K | 0.01% | 891 |
|
|
2025
Q3 | $1.77M | Hold |
32,255
| – | – | ﹤0.01% | 981 |
|
|
2025
Q2 | $1.07M | Buy |
32,255
+2,994
| +10% | +$104K | ﹤0.01% | 1194 |
|
|
2025
Q1 | $1.18M | Buy |
29,261
+1,003
| +4% | +$46.1K | ﹤0.01% | 1072 |
|
|
2024
Q4 | $1.33M | Buy |
28,258
+1,882
| +7% | +$97.7K | ﹤0.01% | 1061 |
|
|
2024
Q3 | $1.39M | Buy |
26,376
+4,282
| +19% | +$239K | ﹤0.01% | 957 |
|
|
2024
Q2 | $1.2M | Buy |
22,094
+2,756
| +14% | +$166K | ﹤0.01% | 977 |
|
|
2024
Q1 | $1.36M | Sell |
19,338
-799
| -4% | -$61.8K | ﹤0.01% | 910 |
|
|
2023
Q4 | $1.68M | Buy |
20,137
+2,557
| +15% | +$92.6K | 0.01% | 801 |
|
|
2023
Q3 | $518K | Buy |
17,580
+1,815
| +12% | +$60.4K | ﹤0.01% | 1382 |
|
|
2023
Q2 | $514K | Buy |
15,765
+1,050
| +7% | +$38.8K | ﹤0.01% | 1328 |
|
|
2023
Q1 | $518K | Buy |
14,715
+694
| +5% | +$28.3K | ﹤0.01% | 1269 |
|
|
2022
Q4 | $642K | Buy |
14,021
+3,348
| +31% | +$144K | ﹤0.01% | 1110 |
|
|
2022
Q3 | $517K | Hold |
10,673
| – | – | ﹤0.01% | 1169 |
|
|
2022
Q2 | $419K | Sell |
10,673
-64
| -0.6% | -$2.58K | ﹤0.01% | 1335 |
|
|
2022
Q1 | $395K | Buy |
10,737
+1,386
| +15% | +$49.2K | ﹤0.01% | 1476 |
|
|
2021
Q4 | $426K | Buy |
9,351
+1,076
| +13% | +$41.5K | ﹤0.01% | 1570 |
|
|
2021
Q3 | $296K | Hold |
8,275
| – | – | ﹤0.01% | 1655 |
|
|
2021
Q2 | $164K | Hold |
8,275
| – | – | ﹤0.01% | 1937 |
|
|
2021
Q1 | $192K | Hold |
8,275
| – | – | ﹤0.01% | 1798 |
|
|
2020
Q4 | $172K | Buy |
8,275
+2,585
| +45% | +$47.2K | ﹤0.01% | 1938 |
|
|
2020
Q3 | $123K | Hold |
5,690
| – | – | ﹤0.01% | 1887 |
|
|
2020
Q2 | $134K | Buy |
5,690
+1,477
| +35% | +$27.7K | ﹤0.01% | 1790 |
|
|
2020
Q1 | $50K | Hold |
4,213
| – | – | ﹤0.01% | 1935 |
|
|
2019
Q4 | $45K | Hold |
4,213
| – | – | ﹤0.01% | 2196 |
|
|
2019
Q3 | $48K | Buy |
4,213
+1,865
| +79% | +$23.4K | ﹤0.01% | 2071 |
|
|
2019
Q2 | $26K | Hold |
2,348
| – | – | ﹤0.01% | 2373 |
|
|
2019
Q1 | $19K | Sell |
2,348
-2,078
| -47% | -$15.3K | ﹤0.01% | 2428 |
|
|
2018
Q4 | $28K | Buy |
4,426
+2,594
| +142% | +$19K | ﹤0.01% | 2328 |
|
|
2018
Q3 | $18K | Hold |
1,832
| – | – | ﹤0.01% | 2491 |
|
|
2018
Q2 | $15K | Hold |
1,832
| – | – | ﹤0.01% | 2458 |
|
|
2018
Q1 | $13K | Hold |
1,832
| – | – | ﹤0.01% | 2471 |
|
|
2017
Q4 | $15K | Buy |
+1,832
| New | +$20.8K | ﹤0.01% | 2457 |
|
Other funds holding CYTK
ACA
Zurich Cantonal Bank's CYTK Position: Q2 2026 in Review
Zurich Cantonal Bank increased its Cytokinetics (CYTK) stake by 5% in Q2 2026, buying an estimated $164K and bringing the position to 47,853 shares worth $4.08M. The position accounts for 0.01% of the portfolio, ranked #777.
Zurich Cantonal Bank first reported a position in CYTK in Q4 2017 and has held it in 35 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- Zurich Cantonal Bank held 47,853 shares of Cytokinetics worth $4.08M as of Q2 2026.
- Zurich Cantonal Bank bought 2,280 Cytokinetics shares in Q2 2026, an estimated $164K.
- Cytokinetics made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #777 holding.
- Zurich Cantonal Bank first reported a position in Cytokinetics in Q4 2017 and has held it in 35 quarters since.
- 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.